REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201224:nBw2cQnvRa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 23 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,048,587 2.36% 684,820 0.53%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,414,292 2.65% 1,423,825 1.10%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 209.6100 USD
Purchase 2 211.9900 USD
Purchase 2 209.5350 USD
Purchase 5 209.9580 USD
Purchase 6 210.1300 USD
Purchase 8 209.2100 USD
Purchase 20 209.6600 USD
Purchase 39 208.9089 USD
Purchase 44 209.4900 USD
Purchase 50 212.3000 USD
Purchase 55 209.6985 USD
Purchase 100 208.7900 USD
Purchase 165 209.3168 USD
Purchase 200 209.7850 USD
Purchase 251 210.9574 USD
Purchase 400 209.6150 USD
Purchase 470 209.2341 USD
Purchase 527 211.3208 USD
Purchase 637 209.4591 USD
Purchase 775 209.1369 USD
Purchase 1,164 211.0551 USD
Purchase 1,269 210.8091 USD
Purchase 1,342 210.7553 USD
Purchase 3,495 209.9301 USD
Purchase 5,157 209.4899 USD
Purchase 5,235 209.5993 USD
Purchase 5,269 209.4361 USD
Purchase 5,535 210.6089 USD
Purchase 7,289 210.9491 USD
Purchase 10,151 208.8200 USD
Purchase 13,158 210.7635 USD
Purchase 15,353 209.4478 USD
Purchase 16,053 209.7676 USD
Purchase 20,200 209.4170 USD
Sale 2 208.9500 USD
Sale 3 209.5900 USD
Sale 5 209.9580 USD
Sale 10 209.6550 USD
Sale 20 209.6600 USD
Sale 42 208.9554 USD
Sale 97 208.3200 USD
Sale 100 208.9000 USD
Sale 100 208.7900 USD
Sale 206 209.1068 USD
Sale 300 209.1600 USD
Sale 462 209.0646 USD
Sale 470 209.2341 USD
Sale 510 209.3148 USD
Sale 646 208.9426 USD
Sale 775 209.1369 USD
Sale 837 209.2708 USD
Sale 902 209.3988 USD
Sale 1,008 209.2228 USD
Sale 1,095 208.9581 USD
Sale 1,221 209.3460 USD
Sale 1,273 209.1211 USD
Sale 1,526 209.1944 USD
Sale 3,563 210.2920 USD
Sale 4,034 209.2981 USD
Sale 4,262 209.9946 USD
Sale 4,695 209.7585 USD
Sale 5,335 209.0673 USD
Sale 7,658 208.8200 USD
Sale 11,942 209.6129 USD
Sale 12,906 209.6402 USD
Sale 14,210 209.4885 USD
Sale 33,728 210.6664 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201224005131/en/
(https://www.businesswire.com/news/home/20201224005131/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Wood Group (John)PLC - Form 8.3 WOOD GROUP (JOHN) PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
Announcement